• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

In Vivo . Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens

tetano

Editor, Senior Moderator
In Vivo


. 2023 Jan-Feb;37(1):70-78.
doi: 10.21873/invivo.13055.
Age-related Differences in Immune Reactions to SARS-CoV-2 Spike and Nucleocapsid Antigens


Patrick Morhart[SUP] 1 [/SUP], Sven Kehl[SUP] 2 [/SUP], Wolfgang Schuh[SUP] 3 [/SUP], Katharina Hermes[SUP] 4 [/SUP], Stefan Meltendorf[SUP] 5 [/SUP], Antje Neubert[SUP] 6 [/SUP], Michael Schneider[SUP] 2 [/SUP], Monika Brunner-Weinzierl[SUP] 5 [/SUP], Holm Schneider[SUP] 6 [/SUP], Holger Lingel[SUP] 5 [/SUP]



Affiliations

Abstract

Background/aim: The manifestation and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections show a clear correlation to the age of a patient. The younger a person, the less likely the infection results in significant illness. To explore the immunological characteristics behind this phenomenon, we studied the course of SARS-CoV-2 infections in 11 households, including 8 children and 6 infants/neonates of women who got infected with SARS-CoV-2 during pregnancy.
Materials and methods: We investigated the immune responses of peripheral blood mononuclear cells (PBMCs), umbilical cord blood mononuclear cells (UCBCs), and T cells against spike and nucleocapsid antigens of SARS-COV-2 by flow cytometry and cytokine secretion assays.
Results: Upon peptide stimulation, UCBC from neonates showed a strongly reduced IFN-γ production, as well as lower levels of IL-5, IL-13, and TNF-α alongside with decreased frequencies of surface CD137/PD-1 co-expressing CD4[SUP]+[/SUP] and CD+8 T cells compared with adult PBMCs. The PBMC response of older children instead was characterized by elevated frequencies of IFN-γ+ CD4[SUP]+[/SUP] T cells, but significantly lower levels of multiple cytokines (IL-5, IL-6, IL-9, IL-10, IL-17A, and TNF-α) and a marked shift of the CD4[SUP]+[/SUP]/CD8[SUP]+[/SUP] T-cell ratio towards CD8[SUP]+[/SUP] T cells in comparison to adults.
Conclusion: The increased severity of SARS-CoV-2 infections in adults could result from the strong cytokine production and lower potential to immunomodulate the excessive inflammation, while the limited IFN-γ production of responding T cells in infants/neonates and the additional higher frequencies of CD8[SUP]+[/SUP] T cells in older children may provide advantages during the course of a SARS-CoV-2 infection.

Keywords: COVID-19; SARS-CoV-2; children; immune response; inflammation; neonates; pediatric immunology; spike protein.
 
Back
Top Bottom